chlorpropamide has been researched along with Parodontosis in 1 studies
Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate if type 2 diabetes mellitus increase gingival crevicular fluid (GCF) levels of prostaglandin E(2) (PGE(2)), interleukin-1beta (IL-1beta), tissue-type plasminogen activator (t-PA), and plasminogen activator inhibitor-2 (PAI-2)." | 1.35 | Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. ( Biyikoğlu, B; Buduneli, N; Cetinkalp, S; Kardeşler, L; Kütükçüler, N, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kardeşler, L | 1 |
| Buduneli, N | 1 |
| Biyikoğlu, B | 1 |
| Cetinkalp, S | 1 |
| Kütükçüler, N | 1 |
1 other study available for chlorpropamide and Parodontosis
| Article | Year |
|---|---|
Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease.
Topics: Adult; Aged; Chlorpropamide; Dental Plaque; Diabetes Mellitus, Type 2; Dinoprostone; Enzyme-Linked I | 2008 |